vs
Commerce.com, Inc.（CMRC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Commerce.com, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$89.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 2.9%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-2.2M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 5.5%）
SPS Commerce是一家总部位于美国明尼苏达州明尼阿波利斯市的科技企业，核心业务是为客户提供基于云端的供应链管理软件解决方案。公司除在美国本土设有分支机构外，还在阿姆斯特丹、北京、香港、多伦多、悉尼等全球多个城市布局了办公网点。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CMRC vs PBYI — 直观对比
营收规模更大
CMRC
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出24.9%
2.9%
自由现金流更多
PBYI
多$16.6M
$-2.2M
两年增速更快
PBYI
近两年复合增速
5.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $89.5M | $75.5M |
| 净利润 | $-8.4M | — |
| 毛利率 | 78.3% | 69.3% |
| 营业利润率 | -7.4% | 22.7% |
| 净利率 | -9.3% | — |
| 营收同比 | 2.9% | 27.7% |
| 净利润同比 | -250.0% | — |
| 每股收益（稀释后） | $-0.11 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMRCPBYI
| Q4 25 | $89.5M | $75.5M | ||
| Q3 25 | $86.0M | $54.5M | ||
| Q2 25 | $84.4M | $52.4M | ||
| Q1 25 | $82.4M | $46.0M | ||
| Q4 24 | $87.0M | $59.1M | ||
| Q3 24 | $83.7M | $80.5M | ||
| Q2 24 | $81.8M | $47.1M | ||
| Q1 24 | $80.4M | $43.8M |
净利润CMRCPBYI
| Q4 25 | $-8.4M | — | ||
| Q3 25 | $-2.2M | $8.8M | ||
| Q2 25 | $-8.4M | $5.9M | ||
| Q1 25 | $-353.0K | $3.0M | ||
| Q4 24 | $-2.4M | — | ||
| Q3 24 | $-7.0M | $20.3M | ||
| Q2 24 | $-11.3M | $-4.5M | ||
| Q1 24 | $-6.4M | $-4.8M |
毛利率CMRCPBYI
| Q4 25 | 78.3% | 69.3% | ||
| Q3 25 | 78.4% | 77.7% | ||
| Q2 25 | 79.0% | 76.5% | ||
| Q1 25 | 79.4% | 77.1% | ||
| Q4 24 | 77.6% | 76.4% | ||
| Q3 24 | 76.3% | 63.9% | ||
| Q2 24 | 75.8% | 77.4% | ||
| Q1 24 | 77.1% | 75.5% |
营业利润率CMRCPBYI
| Q4 25 | -7.4% | 22.7% | ||
| Q3 25 | -0.5% | 17.6% | ||
| Q2 25 | -8.0% | 12.7% | ||
| Q1 25 | -2.9% | 8.7% | ||
| Q4 24 | -0.9% | 22.6% | ||
| Q3 24 | -23.0% | 27.4% | ||
| Q2 24 | -16.5% | -4.6% | ||
| Q1 24 | -10.2% | -5.3% |
净利率CMRCPBYI
| Q4 25 | -9.3% | — | ||
| Q3 25 | -2.6% | 16.2% | ||
| Q2 25 | -9.9% | 11.2% | ||
| Q1 25 | -0.4% | 6.5% | ||
| Q4 24 | -2.7% | — | ||
| Q3 24 | -8.4% | 25.2% | ||
| Q2 24 | -13.8% | -9.6% | ||
| Q1 24 | -8.0% | -11.0% |
每股收益（稀释后）CMRCPBYI
| Q4 25 | $-0.11 | $0.26 | ||
| Q3 25 | $-0.03 | $0.17 | ||
| Q2 25 | $-0.10 | $0.12 | ||
| Q1 25 | $0.00 | $0.06 | ||
| Q4 24 | $-0.03 | $0.40 | ||
| Q3 24 | $-0.09 | $0.41 | ||
| Q2 24 | $-0.15 | $-0.09 | ||
| Q1 24 | $-0.08 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.1M | $97.5M |
| 总债务越低越好 | $157.0M | $22.7M |
| 股东权益账面价值 | $39.4M | $130.3M |
| 总资产 | $308.8M | $216.3M |
| 负债/权益比越低杠杆越低 | 3.99× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CMRCPBYI
| Q4 25 | $141.1M | $97.5M | ||
| Q3 25 | $142.0M | $94.4M | ||
| Q2 25 | $134.5M | $96.0M | ||
| Q1 25 | $120.7M | $93.2M | ||
| Q4 24 | $178.2M | $101.0M | ||
| Q3 24 | $168.4M | $96.7M | ||
| Q2 24 | $275.8M | $96.8M | ||
| Q1 24 | $265.2M | $107.2M |
总债务CMRCPBYI
| Q4 25 | $157.0M | $22.7M | ||
| Q3 25 | $157.3M | $34.0M | ||
| Q2 25 | $157.5M | $45.3M | ||
| Q1 25 | $157.8M | $56.7M | ||
| Q4 24 | $216.5M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | $340.9M | $90.7M | ||
| Q1 24 | $340.5M | $102.0M |
股东权益CMRCPBYI
| Q4 25 | $39.4M | $130.3M | ||
| Q3 25 | $42.8M | $115.3M | ||
| Q2 25 | $38.8M | $104.7M | ||
| Q1 25 | $38.1M | $97.1M | ||
| Q4 24 | $33.4M | $92.1M | ||
| Q3 24 | $29.0M | $71.1M | ||
| Q2 24 | $26.1M | $48.5M | ||
| Q1 24 | $26.9M | $51.0M |
总资产CMRCPBYI
| Q4 25 | $308.8M | $216.3M | ||
| Q3 25 | $309.5M | $202.9M | ||
| Q2 25 | $302.5M | $194.9M | ||
| Q1 25 | $286.3M | $196.2M | ||
| Q4 24 | $340.3M | $213.3M | ||
| Q3 24 | $335.1M | $220.7M | ||
| Q2 24 | $452.5M | $205.0M | ||
| Q1 24 | $442.5M | $214.1M |
负债/权益比CMRCPBYI
| Q4 25 | 3.99× | 0.17× | ||
| Q3 25 | 3.67× | 0.30× | ||
| Q2 25 | 4.06× | 0.43× | ||
| Q1 25 | 4.14× | 0.58× | ||
| Q4 24 | 6.49× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | 13.06× | 1.87× | ||
| Q1 24 | 12.65× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $980.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.2M | $14.4M |
| 自由现金流率自由现金流/营收 | -2.4% | 19.1% |
| 资本支出强度资本支出/营收 | 3.5% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $16.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CMRCPBYI
| Q4 25 | $980.0K | $14.4M | ||
| Q3 25 | $10.6M | $9.7M | ||
| Q2 25 | $13.6M | $14.1M | ||
| Q1 25 | $401.0K | $3.6M | ||
| Q4 24 | $12.4M | $15.6M | ||
| Q3 24 | $5.6M | $11.0M | ||
| Q2 24 | $11.7M | $1.0M | ||
| Q1 24 | $-3.4M | $11.2M |
自由现金流CMRCPBYI
| Q4 25 | $-2.2M | $14.4M | ||
| Q3 25 | $7.6M | $9.7M | ||
| Q2 25 | $11.9M | $14.1M | ||
| Q1 25 | $-424.0K | $3.6M | ||
| Q4 24 | $11.6M | $15.6M | ||
| Q3 24 | $4.5M | $11.0M | ||
| Q2 24 | $10.7M | $1.0M | ||
| Q1 24 | $-4.2M | — |
自由现金流率CMRCPBYI
| Q4 25 | -2.4% | 19.1% | ||
| Q3 25 | 8.8% | 17.7% | ||
| Q2 25 | 14.1% | 26.8% | ||
| Q1 25 | -0.5% | 7.7% | ||
| Q4 24 | 13.3% | 26.4% | ||
| Q3 24 | 5.4% | 13.7% | ||
| Q2 24 | 13.0% | 2.1% | ||
| Q1 24 | -5.3% | — |
资本支出强度CMRCPBYI
| Q4 25 | 3.5% | 0.0% | ||
| Q3 25 | 3.4% | 0.0% | ||
| Q2 25 | 2.0% | 0.0% | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 1.3% | 0.0% | ||
| Q2 24 | 1.3% | 0.0% | ||
| Q1 24 | 1.0% | 0.0% |
现金转化率CMRCPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMRC
| Subscription And Circulation | $65.2M | 73% |
| Partner And Services | $24.4M | 27% |
PBYI
暂无分部数据
